NEW YORK, Feb. 8, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) (“NeoStem” or the “Company”), announced today that the Company and Progenitor Cell Therapy (“PCT”), a NeoStem company, will be presenting at two upcoming conferences in February.
